Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Oxidized resorbable cellulose (Gelita-cel) causing foreign body reaction in the mediastinum

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Preoperative pulmonary function in all comers for cardiac surgery predicts mortality†

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Influence of external stenting on venous graft flow parameters in coronary artery bypass grafting: a randomized study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Coagulation profile in open and video-assisted thoracoscopic lobectomies: a cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Measures of right ventricular function after transcatheter versus surgical aortic valve replacement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Longevity and admission to nursing home according to age after isolated coronary artery bypass surgery: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Behandling af tymom og thymuskarcinom

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Benefits of omitting chest drain after thoracoscopic major lung resection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Different types of oxidized cellulose have been used for haemorrhage control in thoracic surgery, abdominal surgery and neurosurgery. Oxidized resorbable cellulose (Gelita-cel) is a new haemostatic agent. Once saturated with blood, it swells and makes a gelatinous mass that formats as a fibrin clot. We have performed a prospective observational cohort study of patients operated for lung cancer or suspected lung cancer using Gelita-cel as a haemostatic agent. Between October 2010 and April 2012, 477 patients were operated in our department for lung cancer. Gelita-cel was used in 200 patients due to minor intraoperative haemorrhage after lymph node resection from Stations 2 to 11. During follow-up for lung cancer, computed tomography, which was performed 4-60 months after the primary operation, showed enlarged lymph nodes in the mediastinum in 16 patients. Endoscopic bronchial ultrasonographic biopsies of the lymph nodes showed foreign body material and granulomatous inflammation, and no sign of lung cancer recurrence. Gelita-cel has a high risk of causing granuloma and should not be used as a haemostatic agent in thoracic surgery.

OriginalsprogEngelsk
TidsskriftInteractive Cardiovascular and Thoracic Surgery
Vol/bind27
Udgave nummer6
Sider (fra-til)881-883
Antal sider3
ISSN1569-9293
DOI
StatusUdgivet - 1 dec. 2018

ID: 56416360